Add like
Add dislike
Add to saved papers

Insights on inhibition of Plasmodium falciparum plasmepsin I by novel epoxyazadiradione derivatives - Molecular docking and Comparative molecular field analysis.

In the present study, we have explored the anti-malarial potential of epoxyazadiradione, the natural entity extracted from the neem seed oil and its chemical derivatives, against Plasmodium falciparum. The Surflex dock analysis of forty one compounds against an indispensable target, plasmepsin I revealed that around 70% of the compounds are found to have good binding capacity with the Consensus score of 5 to 4 with few hydrogen bonds. To elucidate the major structural requirements, vital for binding with the plasmepsin enzyme and to develop the predictive models, 3-Dimentional Quantitative Structure Activity Relationship - Comparative Molecular Field Analysis was carried out using Sybyl X.0. Robust and predictive models were obtained with cross-validated correlation coefficient (q2 ) value of 0.967 and the non-cross-validated correlation coefficient (r2 ) value of 0.825, which were validated by an external test set with the predictive correlation coefficient r2 (pred) values of 0.773. Three zones were identified for substitution with bulky groups and one zone for substitution with non bulky groups. Three positions favouring the electronegative group substitution and one for the electropositive group substitution were identified. The physicochemical properties of ligands with the highest C-score were studied.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app